PRE Prenetics Global Limited: רווח נקי למניה בארבעת הרבעונים האחרונים
Prenetics Global dominates the personalized medicine segment by making genetic testing accessible to the general population. High barriers to entry are created by rapid diagnostic patents and an extensive Asian laboratory network. Reagent supply is secured through long-term deals and digital logistics. The current figure stands at -5.60, which the EPS (TTM) price visualization below confirms.
PRE (Prenetics Global Limited): פילוחים אנליטיים ודוחות לפי אינדיקטורים
The annual growth rate of net income per share determines the actual speed of fundamental business development over twelve months. This metric compares current aggregate income with the same period last year, filtering out short-term market noise. Analyzing the EPS YoY TTM growth value helps determine trend sustainability and prevents overpaying for an asset. The patent protection of molecular diagnostics at Prenetics Global (PRE) creates barriers for competitors, ensuring the stability of this financial momentum.
